Structured evidence table for Chromium Insulin Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Chromium Insulin Meta-Analysis | Chromium supplementation has been associated with encouraging improvements in insulin sensitivity. | 1 | Babakr AT (2026) | Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes. |
| Chromium Insulin Meta-Analysis | This comprehensive review delves into the implications of chromium supplementation, particularly chromodulin, in the context of MetS and its associated pathological sequelae. | 1 | Babakr AT (2026) | Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes. |
| Chromium Insulin Meta-Analysis | In conclusion, chromium (Cr) enhances insulin sensitivity by directly activating the insulin receptor kinase, which lowers the required insulin concentration for maximal cellular response and improves glucose uptake and storage. | 1 | Babakr AT (2026) | Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes. |
| Chromium Insulin Meta-Analysis | Metabolic syndrome (MetS) is a complex interplay of interrelated metabolic derangements, including insulin resistance, dyslipidemia, central adiposity, and hypertension, thereby markedly amplifying the predisposition to type 2 diabetes mellitus (T2DM) and cardiovascular morbidities. | 1 | Babakr AT (2026) | Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes. |
| Chromium Insulin Meta-Analysis | This increased hepatic FFA flux contributes to the development of hepatic insulin resistance, resulting in increased hepatic glucose production and increased synthesis and secretion of very-low-density lipoprotein (VLDL) []. | 2 | Xenos Konstantinos (2026) | Effects of Berberine, White Mulberry Leaf Extract and Chromium Picolinate on Body Composition and Insulin Resistance in Adults with Obesity: A Randomized Controlled Trial |
| Chromium Insulin Meta-Analysis | This chronic inflammatory status leads to secondary hyperinsulinemia, as the pancreas attempts to compensate for reduced tissue sensitivity by increasing insulin secretion—a process that ultimately leads to β-cell exhaustion and the onset of T2DM []. | 2 | Xenos Konstantinos (2026) | Effects of Berberine, White Mulberry Leaf Extract and Chromium Picolinate on Body Composition and Insulin Resistance in Adults with Obesity: A Randomized Controlled Trial |
| Chromium Insulin Meta-Analysis | It has also been shown to reduce expression of genes involved in gluconeogenesis, such as PEPCK and G6Pase, thereby limiting endogenous hepatic glucose production [].summarizes the principal molecular mechanisms of action of berberine together with their associated metabolic pathways and clinically relevant effects on glucose homeostasis, lipid metabolism, body composition, inflammation, and insulin sensitivity. | 2 | Xenos Konstantinos (2026) | Effects of Berberine, White Mulberry Leaf Extract and Chromium Picolinate on Body Composition and Insulin Resistance in Adults with Obesity: A Randomized Controlled Trial |
| Chromium Insulin Meta-Analysis | 1 Obesity is now recognized worldwide as a chronic, multifactorial disease with serious consequences for public health, quality of life, and the sustainability of health systems. | 2 | Xenos Konstantinos (2026) | Effects of Berberine, White Mulberry Leaf Extract and Chromium Picolinate on Body Composition and Insulin Resistance in Adults with Obesity: A Randomized Controlled Trial |
Source documents